In 60 patients with spinocerebellar ataxia type 12, extended-release propranolol up to 240 mg/day reduced tremor scores vs placebo (TETRAS PS change −4.42 with propranolol at week 8; P<0.001) and improved ataxia and quality of life; fatigue and headache were commonest.
RCTn = 60
Mohapatra et al. Propranolol for Tremors in Spinocerebellar Ataxia Type 12: A Randomized Clinical Trial